NCT06682416 The Impact of Local Anesthetic Solution Temperature on Epidural-related Maternal Fever
| NCT ID | NCT06682416 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of Soochow University |
| Condition | Epidural Related Maternal Fever |
| Study Type | INTERVENTIONAL |
| Enrollment | 424 participants |
| Start Date | 2024-11-30 |
| Primary Completion | 2027-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 424 participants in total. It began in 2024-11-30 with a primary completion date of 2027-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates how the temperature of local anesthetics affects maternal fever related to epidural analgesia during childbirth. The research is a prospective, randomized controlled trial involving 424 participants from two hospitals. The primary objective is to investigate the impact of local anesthetic solution temperature on intrapartum fever in parturients. Secondary goals include assessing the impact on the efficacy of epidural analgesia and various maternal and neonatal outcomes. Participants will receive either 37°C or 23°C anesthetic solutions, and data will be collected on fever rates, pain scores, and other health indicators. The study runs from January 2024 to December 2026.
Eligibility Criteria
Inclusion Criteria: 1. Requesting epidural analgesia; 2. Aged 18 or older; 3. At least 37 weeks of gestation; 4. Those delivering vaginally. Exclusion Criteria: 1. Contraindications to epidural analgesia; 2. Pre-existing fever (≥38°C) before labor; 3. Use of NSAIDs or other types of antipyretics before labor; 4. Multiple pregnancy (carrying more than one fetus); 5. Fetal demise (stillbirth); 6. Severe preeclampsia; 7. Women who refuse to participate.
Contact & Investigator
Fuhai Ji
PRINCIPAL INVESTIGATOR
The First Affiliated Hospital of Soochow University
Frequently Asked Questions
Who can join the NCT06682416 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Epidural Related Maternal Fever. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06682416 currently recruiting?
Yes, NCT06682416 is actively recruiting participants. Contact the research team at hisoka52@outlook.com for enrollment information.
Where is the NCT06682416 trial being conducted?
This trial is being conducted at Suzhou, China, Suzhou, China.
Who is sponsoring the NCT06682416 clinical trial?
NCT06682416 is sponsored by The First Affiliated Hospital of Soochow University. The principal investigator is Fuhai Ji at The First Affiliated Hospital of Soochow University. The trial plans to enroll 424 participants.